Photodynamic therapy 'to go' - a strengths, weaknesses, opportunities and threats analysis

The Role of General Practitioners in Actinic Keratosis Management in Europe: A Dermato-Oncologists Initiative.

Journal of clinical medicine·2026

Knowledge and Risk Perception Regarding Skin Cancer in Immunosuppressed Patients: A Systematic Review and Meta-Analysis.

European journal of investigation in health, psychology and education·2026

Weakly supervised deep learning for cutaneous squamous and basal cell carcinoma in whole-slide histopathology.

The journal of pathology. Clinical research·2026

Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study.

Journal for immunotherapy of cancer·2026

COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant Melanoma.

Cancers·2026

Vision transformer-based diagnosis of psoriasis and eczema in whole-slide histology.

Virchows Archiv : an international journal of pathology·2026

Treatment strategies for interstitial granulomatous dermatitis: Systematic review and expert opinion.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Adverse pregnancy outcomes in women with atopic dermatitis: A systematic review and meta-analysis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Disease progression in hidradenitis suppurativa: A multidimensional framework.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Onvansertib-mediated PLK1 inhibition impairs spermatogenesis in the murine testis.

Asian journal of andrology·2026

RHOA Deletion Downregulates CD19 and Promotes Dysfunctional Immune Microenvironments in CAR-T Resistant Large B-cell Lymphomas.

Blood cancer discovery·2026

BUB1B Mitotic Kinase Dependency Reveals CENP-E Inhibition as a Tractable Approach for Castration and Enzalutamide Resistant Prostate Cancer.

Cancer research·2026

Emerging therapeutic strategies and clinical development of investigational agents for conventional chondrosarcoma.

Expert opinion on investigational drugs·2026

MH-Penile-002: a phase II, prospective, single-arm trial of neoadjuvant anti-EGFR antibody-drug conjugate plus PD-1 inhibitor in penile cancer with challenging penile preservation or regional lymph node metastasis.

Future oncology (London, England)·2026

Real-world treatment patterns in men with metastatic hormone-sensitive prostate cancer in Europe and Asia between 2020 and 2024.

The oncologist·2026

Related Experiment Videos

Photodynamic therapy 'to go' - a strengths, weaknesses, opportunities and threats analysis

Related Concept Videos

The Role of General Practitioners in Actinic Keratosis Management in Europe: A Dermato-Oncologists Initiative.

Knowledge and Risk Perception Regarding Skin Cancer in Immunosuppressed Patients: A Systematic Review and Meta-Analysis.

Weakly supervised deep learning for cutaneous squamous and basal cell carcinoma in whole-slide histopathology.

Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study.

COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant Melanoma.

Vision transformer-based diagnosis of psoriasis and eczema in whole-slide histology.

Treatment strategies for interstitial granulomatous dermatitis: Systematic review and expert opinion.

Adverse pregnancy outcomes in women with atopic dermatitis: A systematic review and meta-analysis.

Disease progression in hidradenitis suppurativa: A multidimensional framework.

Onvansertib-mediated PLK1 inhibition impairs spermatogenesis in the murine testis.

RHOA Deletion Downregulates CD19 and Promotes Dysfunctional Immune Microenvironments in CAR-T Resistant Large B-cell Lymphomas.

BUB1B Mitotic Kinase Dependency Reveals CENP-E Inhibition as a Tractable Approach for Castration and Enzalutamide Resistant Prostate Cancer.

Emerging therapeutic strategies and clinical development of investigational agents for conventional chondrosarcoma.

MH-Penile-002: a phase II, prospective, single-arm trial of neoadjuvant anti-EGFR antibody-drug conjugate plus PD-1 inhibitor in penile cancer with challenging penile preservation or regional lymph node metastasis.

Real-world treatment patterns in men with metastatic hormone-sensitive prostate cancer in Europe and Asia between 2020 and 2024.

Related Experiment Videos

Photodynamic therapy 'to go' - a strengths, weaknesses, opportunities and threats analysis

Related Concept Videos

Related Articles